Your browser doesn't support javascript.
loading
Gliotoxin suppresses NF-κB activation by selectively inhibiting linear ubiquitin chain assembly complex (LUBAC).
Sakamoto, Hiroki; Egashira, Shinichiro; Saito, Nae; Kirisako, Takayoshi; Miller, Simon; Sasaki, Yoshiteru; Matsumoto, Tadahiko; Shimonishi, Manabu; Komatsu, Toru; Terai, Takuya; Ueno, Tasuku; Hanaoka, Kenjiro; Kojima, Hirotatsu; Okabe, Takayoshi; Wakatsuki, Soichi; Iwai, Kazuhiro; Nagano, Tetsuo.
Affiliation
  • Sakamoto H; †Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Egashira S; ‡Open Innovation Center for Drug Discovery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Saito N; ‡Open Innovation Center for Drug Discovery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Kirisako T; §Department of Molecular Cell Biology, Graduate School of Medicine, Osaka City University, Osaka 545-8585, Japan.
  • Miller S; ∥Structural Biology Research Center, Photon Factory, Institute of Materials Structure Science, High-Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-8501, Japan.
  • Sasaki Y; ⧫Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto 606-8501, Japan.
  • Matsumoto T; ⧫Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto 606-8501, Japan.
  • Shimonishi M; ⊥Medical Innovation Center Laboratory for Malignancy Control Research/DSK, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto 606-8501, Japan.
  • Komatsu T; †Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Terai T; †Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Ueno T; †Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Hanaoka K; †Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Kojima H; ‡Open Innovation Center for Drug Discovery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Okabe T; ‡Open Innovation Center for Drug Discovery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Wakatsuki S; ∥Structural Biology Research Center, Photon Factory, Institute of Materials Structure Science, High-Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-8501, Japan.
  • Iwai K; #Department of Structural Biology, Stanford University School of Medicine, Stanford, California 94305, United States.
  • Nagano T; ▽SLAC National Accelerator Laboratory, Menlo Park, California 94025, United States.
ACS Chem Biol ; 10(3): 675-81, 2015 Mar 20.
Article de En | MEDLINE | ID: mdl-25494483
ABSTRACT
A linear ubiquitin chain, which consists of ubiquitin molecules linked via their N- and C-termini, is formed by a linear ubiquitin chain assembly complex (LUBAC) composed of HOIP, HOIL-1L, and SHARPIN, and conjugation of a linear ubiquitin chain on the NF-κB essential modulator (NEMO) is deeply involved in NF-κB activation induced by various signals. Since abnormal activation of NF-κB is associated with inflammatory disease and malignancy, we searched for an inhibitor of LUBAC by high-throughput screening (HTS) with a Tb(3+)-fluorescein FRET system. As a result, we found that the fungal metabolite gliotoxin inhibits LUBAC selectively by binding to the RING-IBR-RING domain of HOIP, the catalytic center of LUBAC. Gliotoxin has been well-known as an inhibitor of NF-κB activation, though its action mechanism has remained elusive. Here, we show that gliotoxin inhibits signal-induced NF-κB activation by selectively inhibiting LUBAC-mediated linear ubiquitin chain formation.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur de transcription NF-kappa B / Ubiquitine / I-kappa B Kinase / Gliotoxine / Immunosuppresseurs Limites: Humans Langue: En Journal: ACS Chem Biol Année: 2015 Type de document: Article Pays d'affiliation: Japon

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur de transcription NF-kappa B / Ubiquitine / I-kappa B Kinase / Gliotoxine / Immunosuppresseurs Limites: Humans Langue: En Journal: ACS Chem Biol Année: 2015 Type de document: Article Pays d'affiliation: Japon